Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy W Jones

Showing results (201-210 of 218) with videos related to

Pageof 22
Sort By:
The Lancet. Diabetes & Endocrinology|January 28, 2017
Exercise management in type 1 diabetes: a consensus statementMichael C Riddell, Ian W Gallen, Carmel E Smart, et al.
Diabetologia|February 19, 2022
Urinary albumin/creatinine ratio tertiles predict risk of diabetic retinopathy progression: a natural history study from the Adolescent Cardio-Renal Intervention Trial (AdDIT) observational cohortPaul Z Benitez-Aguirre, M Loredana Marcovecchio, Scott T Chiesa, et al.
The Journal of Clinical Endocrinology and Metabolism|October 29, 2020
Determinants of Cardiovascular Risk in 7000 Youth With Type 1 Diabetes in the Australasian Diabetes Data NetworkJenny J Couper, Timothy W Jones, Melissa Chee, et al.
The Journal of Clinical Endocrinology and Metabolism|November 11, 2024
Kidney hyperfiltration and mitochondrial changes are associated with eGFR decline in young people with type 1 diabetesUyen N Pham, Alison Pryke, Tracey Baskerville, et al.
Diabetes Technology & Therapeutics|November 12, 2016
Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover StudyAmin Sharifi, Martin I De Bock, Dilshani Jayawardene, et al.
Diabetes Technology & Therapeutics|May 25, 2017
Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose SuspendAnneke Graf, Glenn M Ward, Sara Vogrin, et al.
Diabetes, Obesity & Metabolism|October 29, 2021
Longitudinal audit of assessment and pharmaceutical intervention for cardiovascular risk in the Australasian Diabetes Data NetworkClaire A Robertson, Arul Earnest, Melissa Chee, et al.
Diabetes Care|June 23, 2016
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus ReportDavid M Maahs, Bruce A Buckingham, Jessica R Castle, et al.
BMJ Open Diabetes Research & Care|January 11, 2025
Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia: secondary analysis of a randomized controlled trialJennifer A Halliday, Sienna Russell-Green, Benjamin Lam, et al.
Diabetes Technology & Therapeutics|February 14, 2022
Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During JourneysSteven Trawley, Amanda N Stephens, Sybil A McAuley, et al.
Pageof 22

Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
The Lancet. Diabetes & Endocrinology|January 28, 2017
Exercise management in type 1 diabetes: a consensus statementMichael C Riddell, Ian W Gallen, Carmel E Smart, et al.
Diabetologia|February 19, 2022
Urinary albumin/creatinine ratio tertiles predict risk of diabetic retinopathy progression: a natural history study from the Adolescent Cardio-Renal Intervention Trial (AdDIT) observational cohortPaul Z Benitez-Aguirre, M Loredana Marcovecchio, Scott T Chiesa, et al.
The Journal of Clinical Endocrinology and Metabolism|October 29, 2020
Determinants of Cardiovascular Risk in 7000 Youth With Type 1 Diabetes in the Australasian Diabetes Data NetworkJenny J Couper, Timothy W Jones, Melissa Chee, et al.
The Journal of Clinical Endocrinology and Metabolism|November 11, 2024
Kidney hyperfiltration and mitochondrial changes are associated with eGFR decline in young people with type 1 diabetesUyen N Pham, Alison Pryke, Tracey Baskerville, et al.
Diabetes Technology & Therapeutics|November 12, 2016
Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover StudyAmin Sharifi, Martin I De Bock, Dilshani Jayawardene, et al.
Diabetes Technology & Therapeutics|May 25, 2017
Overnight Counter-Regulatory Hormone Levels and Next Day Glycemia in Adults with Type 1 Diabetes During Closed-Loop Insulin Delivery Versus Sensor-Augmented Pump with Low-Glucose SuspendAnneke Graf, Glenn M Ward, Sara Vogrin, et al.
Diabetes, Obesity & Metabolism|October 29, 2021
Longitudinal audit of assessment and pharmaceutical intervention for cardiovascular risk in the Australasian Diabetes Data NetworkClaire A Robertson, Arul Earnest, Melissa Chee, et al.
Diabetes Care|June 23, 2016
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus ReportDavid M Maahs, Bruce A Buckingham, Jessica R Castle, et al.
BMJ Open Diabetes Research & Care|January 11, 2025
Six months of hybrid closed-loop therapy improves diabetes-specific positive well-being, and reduces diabetes distress and fear of hypoglycemia: secondary analysis of a randomized controlled trialJennifer A Halliday, Sienna Russell-Green, Benjamin Lam, et al.
Diabetes Technology & Therapeutics|February 14, 2022
Driving with Type 1 Diabetes: Real-World Evidence to Support Starting Glucose Level and Frequency of Monitoring During JourneysSteven Trawley, Amanda N Stephens, Sybil A McAuley, et al.
Pageof 22